aducanumab

Alzheimer’s drugs are not the breakthrough promised: Review

A review of more than 20,000 participants found that plaque‑clearing Alzheimer’s drugs offer minimal clinical benefit and carry notable safety…

Alzheimer’s Drug approved in US ‘offers hope’ to millions

Regulators in the US have approved the first new medication for Alzheimer's in nearly two decades. Aducanumab is the first…